fbpx
Biomed Israel 2023: The 21th National Life Science & Technology Week • May 16-18, 2023 | David InterContinental • Tel Aviv, Israel

Biomed Israel 2022 Agenda

Biomed Israel 2022 PROGRAM

TUESDAY, MAY 10

09:00 - 09:15Welcome by Conference Chairpersons:
Ruti Alon, Founder and CEO, Medstrada
Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation
Nissim Darvish, MD, PhD, Managing General Partner, MeOHR Ventures
09:15 - 09:30Coffee Break
HALL A
09:30 - 14:00CELL, GENE AND NUCLEIC ACIDS THERAPIES - THE NEXT FRONTIER IN HUMAN HEALTH
11:00 - 11:30Coffee Break
Chairpersons: Erez Chimovits, Orbimed Partner, Private Equity, Rami Skaliter, PhD, CEO, Cell Cure Neurosciences
09:30 - 09:40Opening Remarks: Erez Chimovits, Orbimed Partner, Private Equity
09:40 - 10:00Sumant Ramachandra, MD, PhD, President and CEO, ImmPACT Bio, "Autologous CAR-T based therapies," "ZOOM"
10:00 - 10:20Chen Schor, President and CEO, Adicet Bio, "Allogeneic CAR-T based therapies"
10:20-10:35
Noam Pilpel, PhD, CTO, Gilboa Therapeutics
10:35 - 10:55Zhen Li, PhD, President and CEO, ADARx Pharmaceuticals, "Oligonucleotide therapeutics"
11:30 - 11:45
Gili Hart, CEO, Splisense
11:45 - 12:05Adel Nada, MD, Co-founder and CEO, GentiBio, "T-regs for curing autoimmunity"
12:05 - 12:25David Baram, PhD, President and CEO, Emendo Biotherapeutics, "Gene editing based therapies"
12:25 - 12:45
Michal Golan Mashiach, PhD, Founder and CEO, EdiTy Therapeutics
12:45 - 13:00Rami Skaliter, PhD, CEO, Cell Cure Neurosciences, "Embrionic stem cells therapies"
13:00 - 13:15
Yona Geffen, PhD, VP, R&D, Gamida Cell
13:15 - 13:30Noam Diamant, PhD, Co-founder and CEO, Noga Therapeutics
13:30 - 13:45Adi Elkeles, PhD, Founder and CEO, Trobix Bio
13:45 - 14:00Prof. Dror Mevorach, MD, CSO, Enlivex Therapeutics, "Allocetra-OTS: High synergistic effectiveness against solid tumor with immune check point inhibitors or CAR T."
14:00 - 15:00Lunch Break
HALL B
09:30 - 14:00MEDICAL DEVICE - BREAKTHROUGH TECHNOLOGIES
11:00 - 11:30Coffee Break
Chairperson: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures
09:30 - 09:45David Rigler, VP Clinical Research and Regulatory Affairs, Nano Retina
09:45 - 10:00Ronen Eckhouse, Co-founder and CEO, Rapid Medical
10:00 - 10:15Amir Danino, Founder and CEO, Innoventric
10:15 - 10:30Shlomit Chappel-Ram, PhD, VP, R&D, Digma Medical
10:30 - 10:45Yotam Drechsler, CEO and Co-founder, BrainQ Technologies
10:45 - 11:05Daniel Goldstein, PhD, Advocate and Patent Attorney, Sanford T. Colb & Co., "Ecosystems and homeostasis: A law and technology look at the field of medical devices"
11:30 - 11:45Ronen Segal, CTO, Alpha Tau Medical
11:45 - 12:00Avner Geva, Founder and CEO, Vensica Therapeutics
12:00 - 12:15Idan Geva, CEO,
12:15 - 12:35Joseph (Joe) Smith, MD, PhD, CSO, Becton Dickinson, "BD - Innovation at Scale"
12:35 - 12:50Benny Dilmoney, CEO, Magneto Thrombectomy Solutions
12:50 - 13:05Gilad Marom, CEO, Restore Medical
13:05 - 13:20Dvir Cohen, CEO and President, Memic Innovative Surgery
13:20 - 13:30Closing Remarks: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures
13:30 - 13:50Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "MedTech 2032: The Future"
14:00 - 15:00Lunch Break
HALL C
09:30-14:00BIO FOOD - NEW ERA OF FOOD TECHNOLOGIES; ITS IMPACT ON NUTRITION AND HEALTH
11:00 - 11:30Coffee Break
Chairperson: Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator
09:30 - 09:55Valerio Nanninni, General Manager, Novozymes Advanced Proteins Solutions, "The food industry perspective and the adaptation of bio-tech technologies"
09:55 - 10:20Matthew Robin, CEO, Mifloma Group-at Migros Industries, "The perspective of a leading FoodTech company, entering the Bio Food arena"
10:20 - 10:45Prof. Yaakov Nahmais, PhD, Founder and President, Future Meat Technologies, "The evolution of a Bio Food Company in the eye of an academic researcher"
10:45 - 11:00Ilan Samish, Phd, Founder and CEO, Amai Proteins
11:30 - 11:55Prof. Eldad Tzahor, PhD, Co-founder and scientific advisor, Profuse Tech, "Bioconversion - the Case Study of Profuse"
11:55 - 12:20Miriam Guggenheim, Co-chair, Covington’s Israel International Initiative, "Regulatory barriers and challenges in adaptation of bio-tech platforms into foods"
12:20 - 12:35Tal Lutzky, Co-founder and CEO, Pigmentum
12:35 - 12:50Neta Lavon, PhD, CTO, Aleph Farm
12:50 - 13:05Orna Harel, PhD, Co-founder and CEO, Sea 2 Cell
13:05 - 13:20Tsipi Shoham, PhD, Co-founder and CEO, GreenOnyx
13:20 - 13:35Iftach Nachman, PhD, Co-founder and Scientific Advisor, Forsea
13:35 - 13:50Fabian Trumper, Co-founder and CEO, Bountica
13:50 - 14:05Prof. Nurit Argov-Argaman, PhD, CTO, Wilk
14:00 - 15:00Lunch Break
PLENARY SESSION
15:15 - 15:45Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, "ZOOM"
Fireside Chat with: Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK
15:45 - 16:15Robert Cohen, MS, President, Digital, Robotics, and Enabling Technology, Stryker, "Orthopedic industry and clinical insights - AI and predictive analytics," "ZOOM"
16:15 - 16:45Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK, "The State of Life Sciences Industry, Today and Tomorrow"
16:45 - 17:15Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "Trials and Tribulations on the Riad to Marketing and Selling your Products to the USA Healthcare System"
17:30 - 20:00Gala Event

WEDNESDAY, MAY 11

HALL A
09:30 - 11:30ACADEMIA - WHERE IS IT TAKING US? SCIENCE AND TECHNOLOGY - PREDICTION AND ANTICIPATION
11:00 - 11:30Coffee Break
Chairperson: Keren Primor Cohen, CEO, Ramot Tel Aviv University
09:30 - 09:35Opening Remarks: Keren Primor Cohen, CEO, Ramot Tel Aviv University
09:35 - 09:42Tamar Harel Adar, PhD, VP R&D, Matricelf
09:42 - 09:49Yan Ostrovski, PhD, Co-founder and CEO, Neshima Medical
09:49 - 09:55Pini Tsukerman, PhD, Co-founder and CEO, > NectinTX Therapeutics
09:55 - 10:02Prof. Ehud Gazit, PhD, Professor, Blavatnik Center for Drug Discovery
10:02 - 10:09Ophir Herbst, CEO, Sequentify
10:09 - 10:14Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University
10:14 - 10:21David Gabay, Co-founder, Chairman and CEO, Madrigal Mental Care
10:21 - 11:35Panel "Building a commercialization marketplace - no more "academic ivory towers""
10:21 - 10:36Moderator: Keren Primor Cohen, CEO, Ramot Tel Aviv University
10:36 - 11:35Yuval Cabilly, PhD, Co-founder and Managing Partner, Israel Biotech Fund
10:36 - 11:35Joel Bar-El, Founder and Executive Chairman, Unicorn Trax
10:36 - 11:35Prof. Jacob (Koby) Rubinstein, PhD, VP, R&D and Chairman, T3 - Technion Technology
10:36 - 11:35Aviv Zeevi, PhD, VP, Head of Division, Israel Innovation Authority
10:36 - 11:35Lior Shahory, General Partner, Peregrine Ventures
HALL A
12:00-14:00BIO CONVERGENCE - ENGINEERING AND BIOTECHNOLOGY COMBINED, EXPANDING TO OTHER VERTICALS
Chairperson: Efi Cohen Arazi, CEO, TanoMed
12:00 - 12:05Opening Remarks: Efi Cohen Arazi, CEO, TanoMed
12:05 - 12:10Dror Bin, CEO, Israel Innovation Authority
12:10 - 12:22Daniel N. Weiss, MD, Medical Director, Enopace Biomedical
12:22 - 12:34Aryeh Batt, CEO and Co-founder, Precise Bio
12:34 - 12:46Ofri Vaisman, COO and General Manager, BlueWind Medical
12:46 - 12:58Iris Alroy, PhD, CSO and CO-founder, Anima Biotech
12:58 - 13:10Alon Meir, PhD, CSO, Seevix Material Sciences
13:10 - 13:22Yuval Mandelbaum, CEO, Discure Technologies
13:22 - 14:00Panel "Bio Convergence talent: the multidisciplinary opportunity and challenge”
Moderator: Daphna Murvitz, Ceo and Co-founder, 8400-The Health Network
Tzvika Hartman, SVP Computational, Biolojic Design
Aryeh Batt, CEO and Co-founder, Precise Bio
Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University,
Merav Bassan, PhD, CDO, BiomX
14:00-15:00Lunch Break
HALL B
09:30 - 14:00AI AND MACHINE LEARNING - TRANSFORMING TREATMENT, DRUG DISCOVERY AND DEVELOPMENT
11:00 - 11:30Coffee Break
Chairperson: Yair Benita, PhD, CTO, AION Labs
09:30 - 09:45Shai Shen-Orr, PhD, Co-founder and Chief Scientist, CytoReason
09:45 - 10:00Micah Pearlman, CEO, Biolojic
10:00 - 10:15Ranit Aharonov, PhD, CTO, Pangea Biomed
10:15 - 10:30Anat Binur, PhD, Co-founder and CEO, UKKO
10:30 - 10:45Noam Solomon, PhD, CEO, Immunai
10:45 - 11:00Isaac Bentwich, MD, Founder and CEO, Quris Technologies
11:30 - 11:45Nadav Askari, PhD, CTO, Genetika+
11:45 - 12:15James Weatherall, PhD, VP, Data Science and Artificial Intelligence, R&D, AztrtaZeneca, "Pushing the boundaries of science through Data Science and Artificial Intelligence," "ZOOM"
12:15 - 12:45Eran Harary, MD, Global Head, Specialty R&D, Teva Pharmaceuticals, "The innovative productivity crisis in the pharmaceutical R&D - Challenges and Potential AI and ML Solutions"
12:45 - 13:15Jason Johnson, PhD, Chief Data and Analytics Officer, SVP, Dana Farber Cancer Institute, "It's about the Data: strategies for enabling and productionizing Al and Machine learning," "ZOOM"
13:15 - 13:45David Berry, MD, PhD, Founder, CEO and General Partner at Flagship Pioneering, Valo Health, "Accelerating drug discovery and development," "ZOOM"
13:45 - 14:00Yair Benita, PhD, CTO, AION Labs
14:00 - 15:00Lunch Break
HALL C
09:30 - 14:00CURRENT AND FUTURE ROLE OF ROBOTICS IN THE MEDICAL FIELD
11:00 - 11:30Coffee Break
Chairperson: Dvir Cohen, CEO and President, Memic Innovative Surgery
09:30 - 09:35Opening Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery
09:35 - 10:00Prof. Alexandre Mottrie, PhD, MD, CEO, Orsi Academy, "Past, present and future of surgical robotics, "ZOOM"
10:00 - 10:25Gus Castello, Cognos-Lux Consulting LLC, "Building operational excellence in surgical robotics"
10:25 - 10:50Michael Kasser, PhD, Director of Regulatory Sciences, Hogan Lovells,
10:50 - 11:05Seong Ryong Kang, PhD, CEO, Korea-Israel industrial R&D foundation (KORIL), "ZOOM" with Hadar Zax, Program Manager at Israel Asia-Pacific Division, "Israel and S. Korea-the lighthouse program"
11:30 - 11:45Michael Conditt, PhD, SVP, Strategic Marketing and Clinical Development, Memic Innovative Surgery
11:45 - 12:00Tami Frenkel, PhD, Co-founder and CEO, Human Xtensions
12:00 - 12:15Chen Levin, CEO, Xact Robotics
12:15 - 12:30Noam Hassidov, CEO, Tamar Robotics
12:30 - 12:45Gaddi Menahem, VP, Head of Intuitive Israel, Intuitive
12:45 - 13:00Yosi Weitzman, Founder, COO/CTO, GM Israeli Site, Carevature Medical
13:00 - 13:15Eyal Morag, MD, CMO, Microbot Medical
13:15 - 13:30Lawrence Obstfeld, CEO, Image Navigation
13:30 - 13:55Maurice R. Ferre, MD, Former co-founder and CEO, Mako Surgical, "Building a robotic company: lessons learned," "ZOOM"
13:55 - 14:00Closing Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery
14:00 - 15:00Lunch Break
PLENARY SESSION
15:15 - 15:35Dror Bin, CEO, Israel Innovation Authority
15:35 - 16:05Janneke Van Der Kamp, Head Region Europe, Novartis, "Bending the Curve of Life:how partnerships can redefine cardiovascular disease care"
16:05 - 16:45Robert S. Langer, DSc, Institute Professor, MIT Department of Chemical Engineering, "ZOOM"
Fireside Chat with: Amy W. Schulman, Managing Partner, Polaris Partners, "ZOOM"
16:45 - 17:15John D. Halamka, MD, MS, President, Mayo Clinic Platform, "ZOOM"

THURSDAY, MAY 12

HALL A
09:30-14:00TRANSFORMATIVE PRECISION CANCER DIAGNOSTICS AND THERAPIES
11:00 - 11:30Coffee Break
Chairperson: Ofer Sharon, MD, CEO, OncoHost
09:30 - 09:35Opening Remarks: Ofer Sharon, MD, CEO, OncoHost, "Precision medicine challenges and opportunities"
09:35 - 09:45Prof. Dror Harats, MD, CEO, VBL Therapeutics, "New Treatment strategies for Solid Tumors: major Leaps, but still work to be done"
09:45 - 10:00Prof. Dror Harats, MD, CEO, VBL Therapeutics
10:00 - 10:15
Roni Mamluk, PhD, Founder and CEO, Ayala Pharma
10:15 - 10:30Isaac Israel, CEO, Purple Biotech
10:30 - 10:45Ilana Mandel, PhD, VP, R&D, Biond Biologics
10:45 - 11:00Eran Ophir, PhD, VP Research and Drug Discovery, Compugen
11:30 - 12:00Reddy Prasanth, MD, SVP, Global Enterprise Oncology Head, Covance/Labcorp Drug Development
12:00 - 12:15Ronen Eavri, PhD, Co-founder and CEO, Barcode Nanotech Next Generation Therapeutics
12:15 - 12:30Ofer Sharon, MD, CEO, OncoHost
12:30 - 12:45Avi Veidman, Co-founder and CEO, Nucleai
12:45 - 13:00Vered Bar, PhD, VP, R&D, Curesponse
13:00 - 13:15Inbal Zafir-Lavie, PhD, CEO and Co-founder, Gina Life
13:15 - 13:30Roi Feingersch, PhD, CEO and Founder, FORESEE GENOMICS
13:30 - 13:45Assaf Halevy, Founder and CEO, 2bPrecise, Genomics and Precision Medicine
14:00 - 15:00Lunch Break
HALL B
09:30-14:00DIGITAL RECONSTRUCTION OF HEALTHCARE
11:00 - 11:30Coffee Break
Chairperson: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
09:30 - 09:35Opening Remarks: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
09:35 - 09:55Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups, Amazon Web Services (AWS), "How Big Tech and High Performance Computing will Impact Healthcare and Life Sciences"
09:55 - 10:15Elliot Menschik, MD, PhD, CDO, Resilience, "Software-defined biomanufacturing of therapeutics"
10:15 - 10:30Avinatan Hassidim, Head of Google Israel research group, Google, "Reimagining the medical record"
10:30 - 10:45Prof. Sam Shah, PhD, Chief Medical Strategy Officer, Numan, "Digital first: building a full stack health provider inside and outside the NHS"
10:45 - 11:00Dedi Gilad, CEO and Co-founder, TytoCare, "The state of virtual care industry in the post-COVID era," Fireside chat with: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel
11:30 - 11:45Amnon Bar Lev, Co-founder and CEO, Alike.Health
11:45 - 12:00Kira Radinsky, PhD, Founder, CEO and CTO, Diagnostic Robotics
12:00 - 12:15Anat Naschitz, Founder and CEO, 9xchange,; Co-founder, OrbiMed Israel, "9xchange, molecule marketplace"
12:15 - 12:30Amir Trabelsi, Co-founder and CEO, Genoox
12:30 - 12:45Orr Inbar, Co-founder and CEO, QuantHealth
12:45 - 13:00Israel (Srulik) Dvorsky, Co-founder and CEO, TailorMed
13:00 - 13:15Itai Gueta, MD, Institue of Clinical Pharmacology, Sheba Tel Ha Shomer Medical Center, "MDCIone - customer perspective"
13:15 - 13:30Eliran Malki, Co-founder and CEO, Belong.Life
13:30 - 13:45Chris Guiffre, CFO and COO, Pear Therapeutics "ZOOM"
14:00 - 15:00Lunch Break
HALL C
09:30 - 14:00INFECTIOUS DISEASES - BREAKING BARRIERS IN VACCINE DEVELOPMENT, THERAPY AND DIAGNOSIS MODALITIES
11:00 - 11:30Coffee Break
Chairperson: Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital
09:35 - 09:55Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital, "Covid19, where are we going?"
10:00 - 10:20BARRY GREENE, CEO, Sage Therapeutics, USA, "COVID exacerbating mental health issues,"
10:20 - 10:40Prof. Jacob Strahilevitz, MD, Head of the department of Infectious Diseases and Clinical Microbiology, Hadassah Medical Center, "Antimicrobial stewardship: A societal need to combat resistance"
10:40 - 11:00Prof. Ronen Ben Ami, MD, Head of the Infectious Diseases Unit, Tel Aviv Medical Center, "Emerging Fungal Threats in 2022"
11:30 - 11:45Nadav Ben-Dov, PhD, CEO and Co-founder, phenofAST
11:45 - 12:00Eynat Finkelshtein, PhD, CSO, Code Pharma
12:00 - 12:15Moshik Cohen-Kutner, PhD, CEO, Omnix Medical
12:15 - 12:30Jonathan Solomon, CEO and Board Member, Biomx
12:30 - 12:45Nadav Kidron, CEO and Chairman of the Board, Oravax Medical
12:45 - 13:00Einat Galamidi Cohen, MD, VP Medical, Enlivex Therapeutics
13:00 - 13:15Ofer Chen, MD, VP Clinical Development, Clew Medical
13:15 - 13:30Yotam Levin, MD, CEO, NanoPass
13:30 - 13:45Eddie Sadan, Co-founder, Terrapeutics
13:45 - 14:00Tamar Ben-Yedida, PhD, CSO, BiondVax Pharmaceuticals
14:00 - 15:00Lunch Break
PLENARY SESSION
15:15 - 15:45Alban de la Sabliere, SVP, Head of Sanofi Partnering Sanofi, France, "Sanofi: Implementing a Play to a Win Strategy"
15:45 - 16:15Ehud Rivlin, PhD, Israel Site Lead Verily, Israel
16:15 - 16:45Tal Zaks, MD, PhD, Venture Partner, Orbimed, USA, "ZOOM"